Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer

Journal Title: International Journal of Reproductive BioMedicine - Year 2016, Vol 14, Issue 4

Abstract

Background: Breast cancer is the most common malignancy in women. Breast Cancer Type 1 Susceptibility gene (BRCA1) is a tumor suppressor gene, involved in DNA damage repair and in 81% of the breast-ovarian cancer families were due to BRCA1. In some clinically investigated genes, the intragenic marker polymorphism is important and the screening of such mutations is faster by using short tandem repeat (STR) polymorphism. Individual polymorphism of STR is a good evidence for following inheritance of repeat polymorphism. Objective: The aim of this study was to evaluate three intragenic BRCA1 marker polymorphisms in families, which have two or more patients with breast/ovarian cancer in comparison to healthy women. Materials and Methods: A total of 107 breast and/or ovarian cancer patients and 93 unrelated healthy women with no clinical phenotype of any malignancy or familial cancer history constitute the study groups. Haplotyping analysis, at 3 intragenic BRCA1 microsatellite markers (D17S855, D17S1322 and D17S1323), were performed for all subject and control groups using labeled primers. Results: After fragment analysis, significance differences were observed as follows: two alleles of D17S855; allele 146 (p=0.02) and 150 (p=0.006), and two alleles of D17S1322, allele 121 (p=0.015) and 142 (p=0.043). These differences were compared with control group. There was significance difference in 8 di/tri allelic haplotypes in present experimental subjects. Some haplotypes were observed to have approximately twice the relation risk for breast cancer. Conclusion: According to recent results, assessment of presence or absence of mentioned alleles in BRCA1 microsatellite can be used for prognosis in individuals, suspected of having or not having the breast cancer.

Authors and Affiliations

Seyed Mohsen Miresmaeili, Dor Mohammad Kordi Tamandani, Seyed Mehdi Kalantar, Seyed Mohammad Moshtaghioun

Keywords

Related Articles

Assessing the efficacy of vaginal hyoscine butyl bromide on cervical ripening prior to intrauterine procedures: A double-blinded clinical trial

Background: Unripe cervix prevents entering the endometrial cavity during intrauterine procedures. Mechanical dilatation of cervical canal might cause undesirable complications. Objective: To investigate the substitute o...

The prevalence of herpes simplex virus type 1 and 2 infection in Iran: A meta-analysis

Background: Seroepidemiologic studies indicate a high prevalence of herpes simplex virus (HSV) infection. This infection leads to ophthalmic, dermatologic, oral, neurologic, vaginal and cervical problems. Different studi...

Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT

Background: Insulin resistance and hyperinsulinemia may play a role in pathogenesis of PCOS. One of the common therapeutic methods is using insulin-sensitizing drugs such as metformin and thiazolidinediones. Objective: T...

Bibliometric mapping and clustering analysis of Iranian papers on reproductive medicine in Scopus database (2010-2014)

Background: To meet the future challenges in the field of reproductive medicine in Iran, better understanding of published studies is needed. Bibliometric methods and social network analysis have been used to measure the...

Download PDF file
  • EP ID EP184512
  • DOI -
  • Views 125
  • Downloads 0

How To Cite

Seyed Mohsen Miresmaeili, Dor Mohammad Kordi Tamandani, Seyed Mehdi Kalantar, Seyed Mohammad Moshtaghioun (2016). Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer. International Journal of Reproductive BioMedicine, 14(4), 271-274. https://europub.co.uk./articles/-A-184512